Much debate surrounds how prosurvival members of the BCL-2 family repress opening of the BAX/BAK channel to block apoptosis; in this issue Llambi et al. (2011) identify two modes of apoptosis inhibition that exhibit surprisingly different behavior upon repeat proapoptotic challenges by BH3-only proteins.
Many forms of apoptosis are initiated due to stress or damage that activates one or more members of the BH3-only subset of the BCL-2 family (Youle and Strasser, 2008) . BH3-only proteins serve as pathway-specific damage or stress sensors that initiate apoptosis through promoting mitochondrial outer membrane permeabilization (MOMP) via a channel comprised of BAX and/or BAK (Chipuk et al., 2010) . Opening of the BAX/BAK channel permits efflux of cytochrome c and other mitochondrial intermembrane space proteins into the cytosol, which seals the fate of the cell through instigation of a proteolytic cascade that coordinates cell demolition (Taylor et al., 2008) . BAX/BAK channel opening is opposed by the prosurvival members of the BCL-2 family, which block cell death as a consequence. Precisely how the prosurvival BCL-2 proteins repress BAX/BAK activation has been much debated. In this issue of Molecular Cell, Green and colleagues reveal that two distinct strategies can be employed by prosurvival BCL-2 family proteins to repress BAX/BAK activation (Llambi et al., 2011) , but these operate with different degrees of effectiveness and have surprising implications for repeat assaults on cellular defenses.
It is well established that BH3-only proteins can, at least in principle, employ two different strategies to trigger BAX/ BAK channel opening (Letai et al., 2002; Kuwana et al., 2005) . BH3-only proteins can either directly bind to BAX or BAK and trigger their activation, or they can bind to the prosurvival members of the BCL-2 family, neutralizing the ability of the latter to sequester BAX/BAK and repress MOMP. However, because of the multiplicity of BCL-2 family members and the potential for interactions between them ( Figure 1A ), it has proved fiendishly difficult to disentangle the specific interactions among members of this family during apoptosis. This has led to a protracted debate revolving around whether prosurvival BCL-2 proteins block MOMP predominantly through binding to BH3-only proteins, to BAX/BAK, or to both. Indeed, there is evidence for both modes of operation (Willis et al., 2007; Mé rino et al., 2009 ) and also for the idea that BH3-only proteins can be divided into two subsets, direct activators and derepressors, depending on their ability to directly activate BAX/BAK or not (Letai et al., 2002; Kuwana et al., 2005) .
What happens in response to a proapoptotic stimulus can be viewed as a game involving opposing teams, the BH3-only proteins and the prosurvival BCL-2 proteins, battling over territorial possession of BAX/BAK. In this scenario, BH3-only proteins mount offensive attacks that are met by the prosurvival BCL-2 family defense. Conceptually, there are at least three defensive strategies that the prosurvival BCL-2 proteins can adopt to block a BH3-only offensive maneuver: they can directly tackle the BH3-only proteins, block access to BAX/BAK, or do both simultaneously. Llambi et al. (2011) have used an elegant approach to analyze these different defensive modes by generating a panel of hybrid BH3-only proteins utilizing the backbone from the BH3-only protein Bid containing the BH3 domain from Bid itself, Bim, BAX, or BAK. This strategy converted Bid from a broad neutralizer of all prosurvival BCL-2 proteins to a protein more selective for specific prosurvival BCL-2 family members, while retaining the ability to directly activate BAX and BAK. This approach enabled Llambi et al. (2011) to trigger MOMP in purified mitochondria under conditions where the different defensive strategies could be examined in isolation.
Where a defensive BCL-2 protein could only bind to an offensive BH3-only protein but not BAX/BAK (called MODE 1) (Figure 1B) , or to BAX/BAK but not the BH3-only (MODE 2) ( Figure 1C) , it was found that MODE 1 required significantly more prosurvival BCL-2 protein to fully block MOMP than was required in MODE 2. Moreover, overcoming a MODE 1 defense through addition of a derepressor BH3-only protein was achieved more readily than derepression of MODE 2. This is most likely because the binding interface and therefore affinity between a prosurvival BCL-2 protein and a BH3-only protein may be lower than the same prosurvival BCL-2 protein binding to BAX or BAK (Ding et al., 2010) . Thus, inhibition of MOMP was more efficient in MODE 2, requiring considerably less prosurvival BCL-2 protein to inhibit a BH3-only offensive challenge. Another key difference found between MODE 1 and 2 is that BAK (and presumably also BAX) underwent conformational changes characteristic of the active form only in MODE 2, as a consequence of direct BH3-only binding, but became locked in complex with prosurvival BCL-2 proteins and remained inactive. This is consistent with a model suggesting that BH3-only, BAX/BAK, and BCL-2 prosurvival proteins can exist in an ''embedded together'' configuration within mitochondrial outer membranes (Lovell et Llambi et al. (2011) made the surprising observation that cells surviving a proapoptotic challenge in MODE 1 as a result of previous exposure to low doses of activated BH3-only proteins were paradoxically easier to derepress, using a small-molecule BH3 mimetic (ABT-737), than cells surviving a higher-intensity challenge of the same stress that engaged MODE 2 ( Figure 1D ). In other words, prior exposure to a low-intensity proapoptotic stress placed cells in a more vulnerable state (i.e., surviving in MODE 1) to a subsequent proapoptotic challenge than cells primed using a higher-intensity dose of the same stimulus (surviving in MODE 2). Because of the relative ease of derepression of MODE 1 versus MODE 2, the former was more readily overpowered than the latter in response to a repeat attack on cellular defenses.
Thus, the study by Llambi et al. suggests that not all defensive strategies within the BCL-2 family are equally robust. Some defensive positions (i.e., MODE 1) can leave cellular defenses compromised such that a repeat attack can lead to more rapid progression to apoptosis. This may have implications for therapeutic strategies aimed at manipulating the BCL-2 family network in diseases such as cancer where cells are often ''primed for death'' through previous encounters with stressors such as hypoxia or nutrient deprivation that trigger activation of BH3-only proteins to sublethal levels (Certo et al., 2006) . A provocative implication of the MODE 1/MODE 2 scenario is that, in at least some therapeutic situations, lower drug doses may well produce more favorable therapeutic response rates in tumors primed for death in MODE 1 rather than MODE 2. In such situations, the old adage that ''less is more'' may be very apt.
Important questions remain. The precise composition of the BAX/BAK pore, whether it is capable of undergoing spontaneous assembly, and whether additional cellular cofactors are required remain unclear. Nonetheless, it is likely that BH3-only mimetic compounds capable of neutralizing prosurvival BCL-2 family defenses will have considerable utility as adjuncts to cancer therapy, serving to derepress the blocks to apoptosis found in many cancers. To minimize side effects on untransformed cells, the challenge will be to identify BH3-mimetics selective for individual prosurvival BCL-2 proteins that are elevated in particular malignancies. Hopefully, derepressing times for the BCL-2 family lie just around the corner. (D) Derepression of a ''primed'' cell surviving in MODE 1 is more readily achieved than a cell surviving in MODE 2 and leads to a more rapid progression to MOMP and apoptosis.
